Drug Trial Radar · NCT01437397
Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Last checked: Nov 19, 2026Latest source record: Mar 23, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,692
Actual
Start
Sep 2011
Primary completion
Feb 2013
Study completion Feb 2013
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Sep 20, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase III study is to assess the maintenance bronchodilator effects of the fixed dose combination versus monotherapies. This study will also assess the effects of the fixed dose combination in terms of COPD symptoms, disease related health status and the long-term safety and tolerability of the fixed dose combination. This study will include a 24 week treatment period, preceding by a run-in period, followed by a two week follow up visit. All patients will be randomized to one of four treatment arms or placebo.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
Aclidinium Bromide/Formoterol FumarateDrug
Inhaled Aclidinium/formoterol FDC 400/12μg, twice per day
Aclidinium Bromide/Formoterol FumarateDrug
Inhaled Aclidinium/formoterol FDC 400/6μg, twice per day
Aclidinium BromideDrug
Inhaled Aclidinium 400 μg, twice per day
Formoterol FumarateDrug
Inhaled Formoterol 12 μg, twice per day
PlaceboDrug
Inhaled dose-matched placebo, twice per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in 1-hour Morning Post-dose Forced Expiratory Volume in One Second (FEV1)Time frame: Week 24 of treatment
- Change From Baseline in Morning Trough Forced Expiratory Volume in One Second (FEV1)Time frame: Week 24 of treatment
Locations
222 sites in 4 countries. Site status is shown where the registry gives one.
Forest Investigative Site 1827
Anniston, Alabama
Forest Investigative Site 1920
Athens, Alabama
Forest Investigative Site 1162
Birmingham, Alabama
Forest Investigative Site 1493
Birmingham, Alabama
Forest Investigative Site 1937
Birmingham, Alabama
Forest Investigative Site 1893
Florence, Alabama
Forest Investigative Site 1824
Gulf Shores, Alabama
Forest Investigative Site 2088
Jasper, Alabama
Forest Investigative Site 1918
Scottsboro, Alabama
Forest Investigative Site 0909
Glendale, Arizona
Forest Investigative Site 1958
Mesa, Arizona
Forest Investigative Site 1379
Phoenix, Arizona
Forest Investigative Site 1822
Anaheim, California
Forest Investigative Site 1483
Buena Park, California
Forest Investigative Site 1809
Fountain Valley, California
Forest Investigative Site 1156
Fresno, California
Forest Investigative Site 1871
Lincoln, California
Forest Investigative Site 1873
Los Angeles, California
Forest Investigative Site 2064
Riverside, California
Forest Investigative Site 1427
Sacramento, California
Forest Investigative Site 1866
Sacramento, California
Forest Investigative Site 1125
San Diego, California
Forest Investigative Site 1898
San Diego, California
Forest Investigative Site 2009
San Diego, California
Forest Investigative Site 1374
Torrance, California
Forest Investigative Site 1813
Tustin, California
Forest Investigative Site 1883
Vista, California
Forest Investigative Site 1380
Golden, Colorado
Forest Investigative Site 1137
Pueblo, Colorado
Forest Investigative Site 1327
Wheat Ridge, Colorado
Forest Investigative Site 1976
Waterbury, Connecticut
Forest Investigative Site 1821
Bay Pines, Florida
Forest Investigative Site 1154
Brandon, Florida
Forest Investigative Site 1944
Brandon, Florida
Forest Investigative Site 1364
Clearwater, Florida
Forest Investigative Site 1152
Clearwater, Florida
Forest Investigative Site 1875
Clearwater, Florida
Forest Investigative Site 0670
DeLand, Florida
Forest Investigative Site 1516
Edgewater, Florida
Forest Investigative Site 0990
Fort Lauderdale, Florida
Showing 40 of 222 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.